Derma Sciences Inc. (DSCI.OB) Completes Worldwide Licensing Agreement for Honey-Based Wound Care Technology
Derma Sciences Inc. is a specialty medical device and pharmaceutical company focusing on advanced wound care. The company today announced it has completed an agreement with healthcare product and life science company Comvita New Zealand Ltd. for the worldwide licensing rights for Derma Sciences’ MEDIHONEY wound and skin care products. Comvita dominates worldwide honey production, controlling about 75 percent of global Leptospermum (manuka) honey production, and is the owner of key intellectual property and patents concerning the use of honey in medical dressings. Derma Sciences currently has licensing rights for North and South America only – about one-third of the…